samedan logo
 
 
spacer
home > ict > autumn 2017 > on the record
PUBLICATIONS
International Clinical Trials

On the Record

Undoubtedly, precision medicine is gaining momentum.
Recent reports put the market on a growth track to reach
$65-75 billion by 2021, with an estimated average growth
rate of 10-12% (1-3). A flurry of announcements regarding
the main focus therapy area, oncology, shows that the field
is attracting a lot of research attention as well as funding.

Cases in point: the $215 million committed to the
Precision Medicine Initiative database in 2015 and
the subsequent $1.45 billion allocated to precision medicine
as part of the 21st Century Cures Act by the Obama
Administration (4). Meanwhile, China launched a five-year,
$3 billion precision medicine initiative in 2016, and the UK
has announced €300 million funding for a four-year project
to map 100,000 of people’s genomes this year (3,5).
The Swiss pharmaceutical hub of Basel – home to powerhouses
Novartis and Roche – has set up a cross-industry innovation
platform for precision medicine, and Qatar has established a
world-class genome project and biobank (6,7).

This surge of activity has been spurred by innovations
in medical technologies, such as drug discovery, companion
diagnostics, next-generation sequencing, bioinformatics
and big data analytics. These allow the diagnosis of certain
diseases based on the analysis of genetic information –
via genomics and specific biomarker techniques – and
the ability to treat particular diseases with new genetic
manipulation methods.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Clinerion'sTigran Arzumanov, PhD, MBA,
has been working in the area of Clinical
Research Sales and Marketing since
2004 and has extensive experience in
commercial aspects of both pharma
research services and eClinical solutions.

Le Vin Chin
is Head of Marketing
and Communications at Clinerion and
has been working in communications
and marketing for 20 years in a wide
variety of industries, including software
and services.
spacer
Tigran Arzumanov
spacer
spacer
spacer
Le Vin Chin
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Charles River Laboratories Announces Extended Relationship with The Michael J. Fox Foundation

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced an extension of its long-standing collaboration with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), a leading organization working to support the diagnosis and treatment of Parkinson’s disease (PD). Since 2011, Charles River and MJFF have worked together to accelerate the discovery of therapies for PD. This latest extension includes grants from MJFF to support two projects:
More info >>

White Papers

PhlexEarchive: The Right Solution for Electronic Archiving of TMF Content

Phlexglobal Ltd

Many sponsor organizations have already recognized the value of moving from paper to electronic Trial Master Files (eTMFs). But few sponsors have taken a more holistic approach to the TMF lifecycle and looked at the entire process from study start-up through archiving of the TMF in electronic format, also known as e-archiving. The recurring value of managing, tracking, maintaining and accessing electronic files should not stop at the point of archiving. All of the challenges of managing an active paper TMF carry through to a paper archive. All of the benefits of an electronic TMF also carry through to the electronic archive. As companies look to move their compliance assets to secure, long-term storage, it is important to consider ongoing compliance requirements, security, accessibility, efficiency and costs of archiving TMF content in a digital format.
More info >>

 
Industry Events

Clinical Trial Supply West Coast 2018

23-24 May 2018, Burlingame, CA

Clinical Trial Supply West Coast is returning for its 11th edition to share strategies for improving the efficiency of their clinical supply chain operations. The programme covers a broad range of topics including GMP compliance, transport management software, change control, machine learning, QP release and overcoming customs delays.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement